nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.136	0.215	CbGbCtD
Ticagrelor—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.092	0.145	CbGbCtD
Ticagrelor—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0877	0.139	CbGbCtD
Ticagrelor—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0782	0.124	CbGbCtD
Ticagrelor—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0766	0.121	CbGbCtD
Ticagrelor—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0723	0.114	CbGbCtD
Ticagrelor—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0459	0.0726	CbGbCtD
Ticagrelor—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0433	0.0685	CbGbCtD
Ticagrelor—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00258	0.08	CbGpPWpGaD
Ticagrelor—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00228	0.0707	CbGpPWpGaD
Ticagrelor—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00187	0.0578	CbGpPWpGaD
Ticagrelor—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00337	CcSEcCtD
Ticagrelor—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00336	CcSEcCtD
Ticagrelor—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00336	CcSEcCtD
Ticagrelor—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00335	CcSEcCtD
Ticagrelor—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00335	CcSEcCtD
Ticagrelor—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00334	CcSEcCtD
Ticagrelor—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.00331	CcSEcCtD
Ticagrelor—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00331	CcSEcCtD
Ticagrelor—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00329	CcSEcCtD
Ticagrelor—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00329	CcSEcCtD
Ticagrelor—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00328	CcSEcCtD
Ticagrelor—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00326	CcSEcCtD
Ticagrelor—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00325	CcSEcCtD
Ticagrelor—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00324	CcSEcCtD
Ticagrelor—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00323	CcSEcCtD
Ticagrelor—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00322	CcSEcCtD
Ticagrelor—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00319	CcSEcCtD
Ticagrelor—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00319	CcSEcCtD
Ticagrelor—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00318	CcSEcCtD
Ticagrelor—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00318	CcSEcCtD
Ticagrelor—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00317	CcSEcCtD
Ticagrelor—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00317	CcSEcCtD
Ticagrelor—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00317	CcSEcCtD
Ticagrelor—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00314	CcSEcCtD
Ticagrelor—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00314	CcSEcCtD
Ticagrelor—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00313	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00312	CcSEcCtD
Ticagrelor—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00311	CcSEcCtD
Ticagrelor—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00309	CcSEcCtD
Ticagrelor—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00309	CcSEcCtD
Ticagrelor—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00308	CcSEcCtD
Ticagrelor—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00308	CcSEcCtD
Ticagrelor—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00307	CcSEcCtD
Ticagrelor—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00305	CcSEcCtD
Ticagrelor—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00303	CcSEcCtD
Ticagrelor—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00302	CcSEcCtD
Ticagrelor—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00302	CcSEcCtD
Ticagrelor—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00302	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00101	0.0313	CbGpPWpGaD
Ticagrelor—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.003	CcSEcCtD
Ticagrelor—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.003	CcSEcCtD
Ticagrelor—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.003	CcSEcCtD
Ticagrelor—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00101	0.003	CcSEcCtD
Ticagrelor—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.001	0.00298	CcSEcCtD
Ticagrelor—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000999	0.00298	CcSEcCtD
Ticagrelor—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000999	0.00298	CcSEcCtD
Ticagrelor—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000994	0.00296	CcSEcCtD
Ticagrelor—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000991	0.00295	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000991	0.00295	CcSEcCtD
Ticagrelor—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000985	0.00294	CcSEcCtD
Ticagrelor—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000983	0.00293	CcSEcCtD
Ticagrelor—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000981	0.00293	CcSEcCtD
Ticagrelor—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000979	0.00292	CcSEcCtD
Ticagrelor—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000977	0.00291	CcSEcCtD
Ticagrelor—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000966	0.00288	CcSEcCtD
Ticagrelor—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000966	0.00288	CcSEcCtD
Ticagrelor—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000954	0.00284	CcSEcCtD
Ticagrelor—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000949	0.00283	CcSEcCtD
Ticagrelor—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000948	0.0293	CbGpPWpGaD
Ticagrelor—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000943	0.00281	CcSEcCtD
Ticagrelor—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000943	0.00281	CcSEcCtD
Ticagrelor—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000913	0.00272	CcSEcCtD
Ticagrelor—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000913	0.00272	CcSEcCtD
Ticagrelor—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000913	0.00272	CcSEcCtD
Ticagrelor—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000907	0.0027	CcSEcCtD
Ticagrelor—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000894	0.00267	CcSEcCtD
Ticagrelor—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000889	0.00265	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000876	0.00261	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000872	0.0026	CcSEcCtD
Ticagrelor—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000872	0.0026	CcSEcCtD
Ticagrelor—Cough—Formoterol—chronic obstructive pulmonary disease	0.000872	0.0026	CcSEcCtD
Ticagrelor—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000864	0.00258	CcSEcCtD
Ticagrelor—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000863	0.00257	CcSEcCtD
Ticagrelor—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000863	0.00257	CcSEcCtD
Ticagrelor—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000862	0.00257	CcSEcCtD
Ticagrelor—Cough—Montelukast—chronic obstructive pulmonary disease	0.000854	0.00255	CcSEcCtD
Ticagrelor—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000851	0.00254	CcSEcCtD
Ticagrelor—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000851	0.00254	CcSEcCtD
Ticagrelor—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000848	0.00253	CcSEcCtD
Ticagrelor—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000847	0.00252	CcSEcCtD
Ticagrelor—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000847	0.00252	CcSEcCtD
Ticagrelor—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000846	0.00252	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000845	0.00252	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000845	0.00252	CcSEcCtD
Ticagrelor—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000829	0.00247	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000827	0.00247	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000826	0.00246	CcSEcCtD
Ticagrelor—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000823	0.00245	CcSEcCtD
Ticagrelor—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000815	0.00243	CcSEcCtD
Ticagrelor—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000813	0.00242	CcSEcCtD
Ticagrelor—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.00239	CcSEcCtD
Ticagrelor—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00238	CcSEcCtD
Ticagrelor—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00238	CcSEcCtD
Ticagrelor—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000799	0.00238	CcSEcCtD
Ticagrelor—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000792	0.00236	CcSEcCtD
Ticagrelor—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000792	0.00236	CcSEcCtD
Ticagrelor—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000789	0.00235	CcSEcCtD
Ticagrelor—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000783	0.00233	CcSEcCtD
Ticagrelor—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000776	0.00231	CcSEcCtD
Ticagrelor—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000762	0.00227	CcSEcCtD
Ticagrelor—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000762	0.00227	CcSEcCtD
Ticagrelor—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000758	0.00226	CcSEcCtD
Ticagrelor—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000758	0.00226	CcSEcCtD
Ticagrelor—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00225	CcSEcCtD
Ticagrelor—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000748	0.00223	CcSEcCtD
Ticagrelor—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000744	0.00222	CcSEcCtD
Ticagrelor—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000733	0.00219	CcSEcCtD
Ticagrelor—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000727	0.00217	CcSEcCtD
Ticagrelor—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.00217	CcSEcCtD
Ticagrelor—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000726	0.0225	CbGpPWpGaD
Ticagrelor—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00072	0.00215	CcSEcCtD
Ticagrelor—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000719	0.00214	CcSEcCtD
Ticagrelor—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000718	0.00214	CcSEcCtD
Ticagrelor—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000718	0.00214	CcSEcCtD
Ticagrelor—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000717	0.00214	CcSEcCtD
Ticagrelor—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000715	0.00213	CcSEcCtD
Ticagrelor—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000709	0.00211	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000704	0.0021	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000704	0.0021	CcSEcCtD
Ticagrelor—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000703	0.0021	CcSEcCtD
Ticagrelor—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000703	0.0021	CcSEcCtD
Ticagrelor—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000703	0.0021	CcSEcCtD
Ticagrelor—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000697	0.00208	CcSEcCtD
Ticagrelor—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000697	0.00208	CcSEcCtD
Ticagrelor—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00206	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00069	0.00206	CcSEcCtD
Ticagrelor—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000689	0.00205	CcSEcCtD
Ticagrelor—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.00205	CcSEcCtD
Ticagrelor—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000681	0.00203	CcSEcCtD
Ticagrelor—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000678	0.00202	CcSEcCtD
Ticagrelor—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000676	0.00201	CcSEcCtD
Ticagrelor—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000675	0.00201	CcSEcCtD
Ticagrelor—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000672	0.002	CcSEcCtD
Ticagrelor—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000672	0.002	CcSEcCtD
Ticagrelor—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000671	0.002	CcSEcCtD
Ticagrelor—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000669	0.00199	CcSEcCtD
Ticagrelor—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000668	0.00199	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000667	0.00199	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000667	0.00199	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00198	CcSEcCtD
Ticagrelor—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000664	0.00198	CcSEcCtD
Ticagrelor—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000658	0.00196	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000653	0.00195	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000653	0.00195	CcSEcCtD
Ticagrelor—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00192	CcSEcCtD
Ticagrelor—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00192	CcSEcCtD
Ticagrelor—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00192	CcSEcCtD
Ticagrelor—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00192	CcSEcCtD
Ticagrelor—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000642	0.00192	CcSEcCtD
Ticagrelor—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000637	0.0019	CcSEcCtD
Ticagrelor—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000636	0.0019	CcSEcCtD
Ticagrelor—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000636	0.0019	CcSEcCtD
Ticagrelor—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.00189	CcSEcCtD
Ticagrelor—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000633	0.00189	CcSEcCtD
Ticagrelor—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000633	0.00189	CcSEcCtD
Ticagrelor—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000631	0.00188	CcSEcCtD
Ticagrelor—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000631	0.00188	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00063	0.00188	CcSEcCtD
Ticagrelor—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000625	0.00186	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000622	0.00185	CcSEcCtD
Ticagrelor—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00181	CcSEcCtD
Ticagrelor—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00181	CcSEcCtD
Ticagrelor—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00179	CcSEcCtD
Ticagrelor—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00179	CcSEcCtD
Ticagrelor—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0006	0.00179	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000597	0.0185	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00175	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000588	0.0182	CbGpPWpGaD
Ticagrelor—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000585	0.00174	CcSEcCtD
Ticagrelor—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000585	0.00174	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000581	0.018	CbGpPWpGaD
Ticagrelor—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000577	0.00172	CcSEcCtD
Ticagrelor—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000577	0.00172	CcSEcCtD
Ticagrelor—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000573	0.00171	CcSEcCtD
Ticagrelor—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.00169	CcSEcCtD
Ticagrelor—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000565	0.00168	CcSEcCtD
Ticagrelor—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000563	0.0174	CbGpPWpGaD
Ticagrelor—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00166	CcSEcCtD
Ticagrelor—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00166	CcSEcCtD
Ticagrelor—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.00165	CcSEcCtD
Ticagrelor—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00163	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000546	0.0169	CbGpPWpGaD
Ticagrelor—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00162	CcSEcCtD
Ticagrelor—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000539	0.00161	CcSEcCtD
Ticagrelor—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000539	0.00161	CcSEcCtD
Ticagrelor—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000528	0.00157	CcSEcCtD
Ticagrelor—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00157	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000521	0.0162	CbGpPWpGaD
Ticagrelor—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00155	CcSEcCtD
Ticagrelor—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00155	CcSEcCtD
Ticagrelor—Rash—Formoterol—chronic obstructive pulmonary disease	0.000514	0.00153	CcSEcCtD
Ticagrelor—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.00153	CcSEcCtD
Ticagrelor—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000514	0.00153	CcSEcCtD
Ticagrelor—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.00153	CcSEcCtD
Ticagrelor—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.00152	CcSEcCtD
Ticagrelor—Headache—Formoterol—chronic obstructive pulmonary disease	0.000511	0.00152	CcSEcCtD
Ticagrelor—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00152	CcSEcCtD
Ticagrelor—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000508	0.00151	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000504	0.0156	CbGpPWpGaD
Ticagrelor—Rash—Montelukast—chronic obstructive pulmonary disease	0.000504	0.0015	CcSEcCtD
Ticagrelor—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000503	0.0015	CcSEcCtD
Ticagrelor—Headache—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00149	CcSEcCtD
Ticagrelor—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.00147	CcSEcCtD
Ticagrelor—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00146	CcSEcCtD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000489	0.0151	CbGpPWpGaD
Ticagrelor—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000486	0.00145	CcSEcCtD
Ticagrelor—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00145	CcSEcCtD
Ticagrelor—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000485	0.00145	CcSEcCtD
Ticagrelor—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00145	CcSEcCtD
Ticagrelor—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000484	0.00144	CcSEcCtD
Ticagrelor—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000484	0.00144	CcSEcCtD
Ticagrelor—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00144	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000476	0.00142	CcSEcCtD
Ticagrelor—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000474	0.00141	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000468	0.0145	CbGpPWpGaD
Ticagrelor—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000467	0.00139	CcSEcCtD
Ticagrelor—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00046	0.00137	CcSEcCtD
Ticagrelor—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.00136	CcSEcCtD
Ticagrelor—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000454	0.00135	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000452	0.00135	CcSEcCtD
Ticagrelor—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000445	0.0138	CbGpPWpGaD
Ticagrelor—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000444	0.00132	CcSEcCtD
Ticagrelor—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000434	0.0013	CcSEcCtD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000434	0.0135	CbGpPWpGaD
Ticagrelor—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000426	0.0132	CbGpPWpGaD
Ticagrelor—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000422	0.00126	CcSEcCtD
Ticagrelor—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00041	0.00122	CcSEcCtD
Ticagrelor—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000409	0.0127	CbGpPWpGaD
Ticagrelor—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000408	0.00122	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.00118	CcSEcCtD
Ticagrelor—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000396	0.00118	CcSEcCtD
Ticagrelor—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000393	0.0122	CbGpPWpGaD
Ticagrelor—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000393	0.00117	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000364	0.00108	CcSEcCtD
Ticagrelor—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00107	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000356	0.011	CbGpPWpGaD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000355	0.011	CbGpPWpGaD
Ticagrelor—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000353	0.00105	CcSEcCtD
Ticagrelor—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000353	0.00105	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000346	0.00103	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000343	0.0106	CbGpPWpGaD
Ticagrelor—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000341	0.0106	CbGpPWpGaD
Ticagrelor—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00101	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000991	CcSEcCtD
Ticagrelor—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00097	CcSEcCtD
Ticagrelor—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000323	0.01	CbGpPWpGaD
Ticagrelor—Shock—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000941	CcSEcCtD
Ticagrelor—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000938	CcSEcCtD
Ticagrelor—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000312	0.000929	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000299	0.00928	CbGpPWpGaD
Ticagrelor—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00921	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000293	0.00909	CbGpPWpGaD
Ticagrelor—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.000871	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000292	0.00904	CbGpPWpGaD
Ticagrelor—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000859	CcSEcCtD
Ticagrelor—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000286	0.00885	CbGpPWpGaD
Ticagrelor—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000842	CcSEcCtD
Ticagrelor—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00083	CcSEcCtD
Ticagrelor—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.000829	CcSEcCtD
Ticagrelor—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000825	CcSEcCtD
Ticagrelor—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.000825	CcSEcCtD
Ticagrelor—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000818	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000271	0.0084	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000268	0.00829	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00829	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000788	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000782	CcSEcCtD
Ticagrelor—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.000782	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000262	0.00812	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.00026	0.00804	CbGpPWpGaD
Ticagrelor—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000756	CcSEcCtD
Ticagrelor—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000756	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00025	0.00774	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.00025	0.00773	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000247	0.00766	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000705	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000233	0.00721	CbGpPWpGaD
Ticagrelor—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000686	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000229	0.00711	CbGpPWpGaD
Ticagrelor—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000677	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000227	0.00702	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000223	0.00692	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000221	0.00685	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000221	0.00683	CbGpPWpGaD
Ticagrelor—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000655	CcSEcCtD
Ticagrelor—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000633	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00021	0.00651	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.00651	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.00021	0.0065	CbGpPWpGaD
Ticagrelor—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000608	CcSEcCtD
Ticagrelor—Rash—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000603	CcSEcCtD
Ticagrelor—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000603	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000201	0.00624	CbGpPWpGaD
Ticagrelor—Headache—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000599	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.0002	0.00619	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000198	0.00614	CbGpPWpGaD
Ticagrelor—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000568	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000183	0.00566	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000182	0.00563	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000178	0.00552	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000177	0.00548	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000175	0.00541	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000174	0.00538	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.00526	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.00017	0.00525	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00519	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000162	0.00502	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000161	0.00499	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00473	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000152	0.00471	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.00015	0.00465	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00015	0.00465	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000147	0.00456	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000142	0.00439	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.00014	0.00432	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00427	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000135	0.00419	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000134	0.00415	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000126	0.00392	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000126	0.00391	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00382	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00377	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000115	0.00355	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000114	0.00353	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000114	0.00352	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000113	0.0035	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000109	0.00337	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000108	0.00334	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000108	0.00334	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000102	0.00317	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.0031	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.87e-05	0.00306	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	9.27e-05	0.00287	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.97e-05	0.00278	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	8.9e-05	0.00276	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.8e-05	0.00273	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.7e-05	0.0027	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.7e-05	0.00269	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.9e-05	0.00245	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.84e-05	0.00243	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.53e-05	0.00233	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.34e-05	0.00227	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.32e-05	0.00227	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.22e-05	0.00223	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.19e-05	0.00223	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.94e-05	0.00215	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.91e-05	0.00214	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.77e-05	0.0021	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.45e-05	0.002	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.1e-05	0.00189	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.1e-05	0.00189	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.05e-05	0.00188	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.02e-05	0.00186	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TP53—chronic obstructive pulmonary disease	5.92e-05	0.00183	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.61e-05	0.00174	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.54e-05	0.00172	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.53e-05	0.00171	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.5e-05	0.0017	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.32e-05	0.00165	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.3e-05	0.00164	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.00162	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.92e-05	0.00152	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.6e-05	0.00142	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.47e-05	0.00139	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.28e-05	0.00132	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.16e-05	0.00129	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.05e-05	0.00125	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.86e-05	0.0012	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.72e-05	0.00115	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.69e-05	0.00114	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.57e-05	0.0011	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.41e-05	0.00106	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.34e-05	0.00104	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.27e-05	0.00101	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.19e-05	0.000987	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.11e-05	0.000964	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.96e-05	0.000917	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.83e-05	0.000877	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.81e-05	0.00087	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.76e-05	0.000854	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.66e-05	0.000823	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.56e-05	0.000794	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.44e-05	0.000757	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.44e-05	0.000755	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.42e-05	0.000748	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.39e-05	0.000741	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.2e-05	0.000683	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.14e-05	0.000663	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.03e-05	0.000629	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.01e-05	0.000622	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.84e-05	0.000569	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.69e-05	0.000525	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.67e-05	0.000517	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.56e-05	0.000482	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.51e-05	0.000466	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-05	0.000461	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.000457	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000421	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.25e-05	0.000388	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000323	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000319	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1e-05	0.000311	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.59e-06	0.000297	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.59e-06	0.000297	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.09e-06	0.000282	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.18e-06	0.000191	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.91e-06	0.000183	CbGpPWpGaD
